Pieris Pharmaceuticals (NSDQ:PIRS) has closed an underwritten public offering of 6,325,000 shares of its common stock.
The Boston, Mass.-based company said it reeled in $50.6 million from the offering, which it plans to use to fund the pre-clinical and clinical development of its pipeline.
Get the full story at our sister site, Drug Delivery Business News.
The post Pieris Pharmaceuticals closes $51m public offering appeared first on MassDevice.
from MassDevice http://ift.tt/2ofUbS0
Cap comentari:
Publica un comentari a l'entrada